Results 161 to 170 of about 6,863,082 (290)

Get the unbalance right: asymmetric transfer effects in cognitive offloading. [PDF]

Cogn Res Princ Implic
Florean I, Stragà M, Mäntylä T, Del Missier F.   +3 more
europepmc   +1 more source

Missed opportunity [PDF]

Canadian Medical Association Journal, 2008
openaire   +2 more sources

Educational Opportunities [PDF]

AORN Journal, 2020
openaire   +2 more sources

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt, Marius Ygonia, Ali Manouchehrinia, Philippe Lefrançois, Ingrid Kockum, Adil Harroud   +5 more
wiley   +1 more source

Erratum: Work-Life Imbalance: A Challenge and an Opportunity for Neurosurgery: Corrigendum. [PDF]

Neurosurg Pract
Shitsama S, Skulsampaopol J, Saha A, Cusimano MD.   +3 more
europepmc   +1 more source

Opportunity and social mobility [PDF]

This study argues that both unequal opportunity and social mobility are necessary implications of an efficient societal arrangement when incentives must be provided.Income ...
Christopher Phelan
core  

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment. [PDF]

Am J Clin Dermatol
Martorell A, Ingram JR, Sayed CJ, Bechara FG, Porter ML, Tzellos T, Naik HB, Kirby B, van Straalen KR, Frew JW, Alarcon I, Jordan M V, Garg A.   +12 more
europepmc   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Integration of a WASH Component in the Standard National Protocol for Treatment of Severe Acute Malnutrition in Children Aged 6-59 Months in Northern Senegal-A Costing Study. [PDF]

Matern Child Nutr
Wassonguema B, Lê-Lacanette M, Braun L, Ba M, Siroma F, Cabo AE, Brizuela AV, Seye M, Lapègue J, Devort A, Cumming O, N'Diaye DS.   +11 more
europepmc   +1 more source